The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

CVS faces significant 2025 headwinds, including intense pharmacy competition, threatened new federal government pressures, ...

We recently published a list of 10 Firms Dominate Monday Upsurge. In this article, we are going to take a look at where CVS ...

Shares of CVS Health Corp. CVS advanced 1.11% to $52.14 Wednesday, on what proved to be an all-around favorable trading ...

Shares of CVS Health Corp. CVS inched 0.10% higher to $51.57 Tuesday, on what proved to be an all-around positive trading ...

This week's dividend activity included increased payouts from Lakeland Financial (LKFN) and Valero Energy (VLO) as well as ...

We recently published a list of 12 Best Fortune 500 Dividend Stocks To Buy Right Now. In this article, we are going to take a ...

CVS faces strong competition from Amazon, Walmart, and Costco, impacting market share. Read why I maintain a Hold rating for ...

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter ...

CVS Health shares are trading lower by 2.7% during Thursday's session. Shares of insurers and pharmacy benefit manager stocks ...

CVS Health (NYSE: CVS) is a stock that's been struggling badly for multiple years and is coming off a brutal performance in ...

According to Benzinga Pro, CVS Health's peer group average for short interest as a percentage of float is 9.89%, which means ...